arXiv subjects

Thomas A. Hope

Publications and source records attributed to Thomas A. Hope.

6 recordsLinked to original sources

arXiv2026

Fine-UNETR for PSMA PET/CT Lesion Segmentation: Automated Tumor Quantification and Overall Survival Stratification in Prostate Cancer

Introduction: To develop and evaluate Fine-UNETR, a Vision Transformer-based architecture for automated segmentation of PSMA-avid lesions on whole-body PET/CT, and to assess clinical utility of AI-derived tumor burden biomarkers for overall survival stratification in radioligand therapy. Methods: In this retrospective study, 373 PSMA PET/CT scans (mean age, 71+-8 years) from patients with prostate cancer were analyzed. Fine-UNETR, a modified UNETR with 8x8x8 voxel patch embedding and axial sliding window training, was trained on 299 scans and validated on 74 scans. Overall survival stratification was assessed in an independent cohort of 67 pre-radioligand therapy patients using Kaplan-Meier analysis and log-rank testing. External validation was performed on 192 cases from the AutoPET IV PSMA PET/CT dataset. Results: Fine-UNETR achieved a Dice similarity coefficient (DSC) of 66.63%, sensitivity of 70.27%, precision of 67.77%, and a lesion detection rate of 79.53% (96.05% for lesions with SUVmax >= 5). On the external validation dataset, the model achieved a DSC of 44.11% and a lesion detection rate of 87.18%, indicating that lesion detection performance was preserved despite reduced voxel-level overlap. AI-derived biomarkers showed excellent agreement with ground truth (total tumor volume: r=0.984; total lesion uptake: r=0.989; lesion count: r=0.960). In the clinical cohort, total tumor volume (p=0.0019), SUVmax (p=0.014), and SUVmean (p=0.016) significantly stratified overall survival. Conclusion: Fine-UNETR enables accurate automated whole-body PSMA lesion segmentation and tumor burden quantification. Performance on an external dataset demonstrates robustness despite evidence of domain shift. AI-derived biomarkers significantly stratified overall survival in a pre-radioligand therapy cohort, supporting the clinical utility of automated PSMA PET/CT quantification for prognostication.

eess.IV↗

arXiv2022

Mixed Supervision of Histopathology Improves Prostate Cancer Classification from MRI

Non-invasive prostate cancer detection from MRI has the potential to revolutionize patient care by providing early detection of clinically-significant disease (ISUP grade group >= 2), but has thus far shown limited positive predictive value. To address this, we present an MRI-based deep learning method for predicting clinically significant prostate cancer applicable to a patient population with subsequent ground truth biopsy results ranging from benign pathology to ISUP grade group~5. Specifically, we demonstrate that mixed supervision via diverse histopathological ground truth improves classification performance despite the cost of reduced concordance with image-based segmentation. That is, where prior approaches have utilized pathology results as ground truth derived from targeted biopsies and whole-mount prostatectomy to strongly supervise the localization of clinically significant cancer, our approach also utilizes weak supervision signals extracted from nontargeted systematic biopsies with regional localization to improve overall performance. Our key innovation is performing regression by distribution rather than simply by value, enabling use of additional pathology findings traditionally ignored by deep learning strategies. We evaluated our model on a dataset of 973 (testing n=160) multi-parametric prostate MRI exams collected at UCSF from 2015-2018 followed by MRI/ultrasound fusion (targeted) biopsy and systematic (nontargeted) biopsy of the prostate gland, demonstrating that deep networks trained with mixed supervision of histopathology can significantly exceed the performance of the Prostate Imaging-Reporting and Data System (PI-RADS) clinical standard for prostate MRI interpretation.

eess.IV↗

arXiv2022

Synthetic PET via Domain Translation of 3D MRI

Historically, patient datasets have been used to develop and validate various reconstruction algorithms for PET/MRI and PET/CT. To enable such algorithm development, without the need for acquiring hundreds of patient exams, in this paper we demonstrate a deep learning technique to generate synthetic but realistic whole-body PET sinograms from abundantly-available whole-body MRI. Specifically, we use a dataset of 56 $^{18}$F-FDG-PET/MRI exams to train a 3D residual UNet to predict physiologic PET uptake from whole-body T1-weighted MRI. In training we implemented a balanced loss function to generate realistic uptake across a large dynamic range and computed losses along tomographic lines of response to mimic the PET acquisition. The predicted PET images are forward projected to produce synthetic PET time-of-flight (ToF) sinograms that can be used with vendor-provided PET reconstruction algorithms, including using CT-based attenuation correction (CTAC) and MR-based attenuation correction (MRAC). The resulting synthetic data recapitulates physiologic $^{18}$F-FDG uptake, e.g. high uptake localized to the brain and bladder, as well as uptake in liver, kidneys, heart and muscle. To simulate abnormalities with high uptake, we also insert synthetic lesions. We demonstrate that this synthetic PET data can be used interchangeably with real PET data for the PET quantification task of comparing CT and MR-based attenuation correction methods, achieving $\leq 7.6\%$ error in mean-SUV compared to using real data. These results together show that the proposed synthetic PET data pipeline can be reasonably used for development, evaluation, and validation of PET/MRI reconstruction methods.

physics.med-ph↗

arXiv2022

Physics-driven Deep Learning for PET/MRI

In this paper, we review physics- and data-driven reconstruction techniques for simultaneous positron emission tomography (PET) / magnetic resonance imaging (MRI) systems, which have significant advantages for clinical imaging of cancer, neurological disorders, and heart disease. These reconstruction approaches utilize priors, either structural or statistical, together with a physics-based description of the PET system response. However, due to the nested representation of the forward problem, direct PET/MRI reconstruction is a nonlinear problem. We elucidate how a multi-faceted approach accommodates hybrid data- and physics-driven machine learning for reconstruction of 3D PET/MRI, summarizing important deep learning developments made in the last 5 years to address attenuation correction, scattering, low photon counts, and data consistency. We also describe how applications of these multi-modality approaches extend beyond PET/MRI to improving accuracy in radiation therapy planning. We conclude by discussing opportunities for extending the current state-of-the-art following the latest trends in physics- and deep learning-based computational imaging and next-generation detector hardware.

eess.IV↗

arXiv2021

Attenuation Coefficient Estimation for PET/MRI With Bayesian Deep Learning pseudo-CT and Maximum Likelihood Estimation of Activity and Attenuation

A major remaining challenge for magnetic resonance-based attenuation correction methods (MRAC) is their susceptibility to sources of MRI artifacts (e.g. implants, motion) and uncertainties due to the limitations of MRI contrast (e.g. accurate bone delineation and density, and separation of air/bone). We propose using a Bayesian deep convolutional neural network that, in addition to generating an initial pseudo-CT from MR data, also produces uncertainty estimates of the pseudo-CT to quantify the limitations of the MR data. These outputs are combined with MLAA reconstruction that uses the PET emission data to improve the attenuation maps. With the proposed approach (UpCT-MLAA), we demonstrate accurate estimation of PET uptake in pelvic lesions and show recovery of metal implants. In patients without implants, UpCT-MLAA had acceptable but slightly higher RMSE than Zero-echo-time and Dixon Deep pseudo-CT when compared to CTAC. In patients with metal implants, MLAA recovered the metal implant; however, anatomy outside the implant region was obscured by noise and crosstalk artifacts. Attenuation coefficients from the pseudo-CT from Dixon MRI were accurate in normal anatomy; however, the metal implant region was estimated to have attenuation coefficients of air. UpCT-MLAA estimated attenuation coefficients of metal implants alongside accurate anatomic depiction outside of implant regions.

physics.med-ph↗

arXiv2020

Bone Material Analogues for PET/MRI Phantoms

Purpose: To develop bone material analogues that can be used in construction of phantoms for simultaneous PET/MRI systems. Methods: Plaster was used as the basis for the bone material analogues tested in this study. It was mixed with varying concentrations of an iodinated CT contrast, a gadolinium-based MR contrast agent, and copper sulfate to modulate the attenuation properties and MRI properties (T1 and T2*). Attenuation was measured with CT and 68Ge transmission scans, and MRI properties were measured with quantitative ultrashort echo time pulse sequences. A proof-of-concept skull was created by plaster casting. Results: Undoped plaster has a 511 keV attenuation coefficient (~0.14 cm-1) similar to cortical bone (0.10-0.15 cm-1), but slightly longer T1 (~500 ms) and T2* (~1.2 ms) MR parameters compared to bone (T1 ~ 300 ms, T2* ~ 0.4 ms). Doping with the iodinated agent resulted in increased attenuation with minimal perturbation to the MR parameters. Doping with a gadolinium chelate greatly reduced T1 and T2*, resulting in extremely short T1 values when the target T2* values were reached, while the attenuation coefficient was unchanged. Doping with copper sulfate was more selective for T2* shortening and achieved comparable T1 and T2* values to bone (after 1 week of drying), while the attenuation coefficient was unchanged. Conclusions: Plaster doped with copper sulfate is a promising bone material analogue for a PET/MRI phantom, mimicking the MR properties (T1 and T2*) and 511 keV attenuation coefficient of human cortical bone.

physics.med-ph↗